noom glp 1 companion Retention, Renewal, Results: Noom's GLP‑1 Anyone else doing Noom w/GLP-1

/PRNewswire/ -- GNC, the global leader in health and wellness, today announced its unprecedented initiative to support individuals using GLP-1 agonists

Drugs like semaglutide and liraglutide have recently gained massive attention not just for diabetes, but for weight loss

However, there was progress in the UK where the government announced Scotland CardioMetabolic Impact Study (SCoMIS) , a pioneering Real-World study, which will provide Wegovy to between 3,000-5,000 people living with Obesity in Scotlands poorest areas free of charge during a three year study [11] Despite FDA phasing out enforcement discretion that allowed GLP-1 compounding during shortages - and setting May 2025 deadlines for compounding to cease - compounding has continued beyond this deadline [12]

The FDA ended the tirzepatide shortage, but 9 pharmacies still legally dispense compounded tirzepatide in 2026

Nu-U.Ai | Post GLP-1 forum & AI chatbot SaaS company profile on GetLatka revenue, ARR, valuation, funding rounds, customers, team size, and growth.

Preclinical studies suggest that GIPR antagonism helps with weight loss and metabolic improvements